Found 39 matching trials
To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion PHASE4 This is an open-label, sing-arm, phase IV clinical study. The study is desi...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) PHASE2 The primary objectives of the trial is to examine the toxicities and effica...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of the com...
Show More Location
2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital
Learn More & Join Trial
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer PHASE2 Patients with stage IIIB and IV lung adenocarcinoma and progression to firs...
Show More Location
National Cancer Institute of Mexico
Learn More & Join Trial
Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification PHASE2 This is a phase 2 trial investigating the effect and safety of afatinib plu...
Show More Location
Peking University Cancer Hospital and Institute
Learn More & Join Trial
GIOTRIF rPMS in Korean Patients With NSCLC N/A To monitor the safety profile and efficacy of GIOTRIF® (afatinib dimaleate,...
Show More Location
Multiple Locations
Learn More & Join Trial
Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01) PHASE2 This is a phase 2 trial investigating the effect and safety of afatinib in ...
Show More Location
Peking University Cancer Hospital and Institute
Learn More & Join Trial
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2 PHASE1 To determine the maximum tolerated dose, safety, pharmacokinetics and anti-...
Show More Location
1200.69.3301 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib N/A Non-interventional, multi-country, multi-centre cohort study based on exist...
Show More Location
Royal Marsden Hospital
Learn More & Join Trial
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC PHASE1 Brain metastases occurs in up to 50% of patients with EGFR mutant NSCLC. Le...
Show More Location
National Cancer Center Singapore
Learn More & Join Trial